Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS
|
|
- Clyde Peters
- 6 years ago
- Views:
Transcription
1 Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS Disclosure Ashley Duty has no conflicts of interest to disclose Joanna Robinson has no conflicts of interest to disclose Objectives 1. Understand the purpose of USP Describe how to engage key stakeholders and implement the required elements of USP Explain what resources are available to implement USP 800 standards 1
2 Overview Background Basic definitions Gap analysis Assessment of risk Non Sterile Compounding Background Awareness of risk Per the CDC, 8 million healthcare workers are potentially exposed 1 Presence of chemotherapy in urine of healthcare workers 2 Long term repercussions of hazardous drug exposure Guidance documents previously released: Oncology Nursing Society (ONS) in 1984 Occupational Safety and Health Administration (OSHA) in 1986 American Society of Health System Pharmacists (ASHP) in Hazardous Drug Exposures in Health Care. Centers for Disease Control and Prevention. 15 Sept Web. 20 Feb Sorsa M, Anderson D. Monitoring of occupational exposure to cytostatic anticancer agents. Mutation Research 355 (1996): Background Release of the USP 800 chapter is a call to action Enforceable standard State BOP and other regulatory bodies can require compliance 6 2
3 Background Scope of USP 800 Receiving Storage Manipulating Administration Disposal 7 Background USP 800 Timeline March 2014 Chapter first published for public comment December 2014 Revisions published, round 2 of public comment February 2016 Final version published in USP NF July 1, 2018 Federally enforceable 463 Days Background USP 800 Chapter Overview List of Hazardous Medications Personal Protective Equipment (PPE) Facilities Design Handling Hazardous Medications Cleaning Medical Surveillance 9 3
4 Basic Definitions Acronym in USP 800 CPEC CSEC CSCA Should Shall or Must Definition Containment Primary Engineering Control Containment Secondary Engineering Control Containment Segregated Compounding Area What it really means The hood The room the hood is in Segregated area, no requirement for ISO classification Recommendation Requirement CPEC: Types of hoods Laminar Airflow Workbench (LAFW) Horizontal Airflow Most common hood found in IV rooms Can NOT be used for HD compounding Biological Safety Cabinet (BSC) Vertical Airflow Often referred to as a Chemo hood Classes and Types with % air recirculation Glove boxes Compounding Aseptic Isolator (CAI) POSITIVE pressure Compounding Aseptic Containment Isolator (CACI) NEGATIVE pressure 11 CPEC: Sterile Compounding of HDs Must be performed in a CPEC within a separate room with ISO Class 5 air Laminar airflow workbench (LAFW) or Compounding Aseptic Isolator (CAI) can NOT be used for compounding HDs isolators flow hoods/horizontal laminar flow hoods.php 12 4
5 Changes from <797> Elimination of low volume exemption currently in <797> All HDs must be compounded in BSC or CACI in a negative pressure room Allowance for CSCA Storage under negative pressure 13 Gap Analysis 14 Conducting a Gap Analysis Compare the best practices with the processes currently in place in your organization Determine the gaps between your organization s practices and the identified best practices Select the best practices you will implement in your organization Get organized! analysis what and how all you need to know/ 15 5
6 Conducting a Gap Analysis Example Current State 65% of hospitalized patients have received the influenza vaccine for Desired State 100% of hospitalized patients have received the influenza vaccine for Identified Gap 35% of hospitalized patients need to receive the influenza vaccine for Barriers to Implementation Misconceptions about vaccination Appropriate documentation about vaccination history Vaccine supply issues 16 gapanalysis.pdf 17 Hazmedsafety.com 18 6
7 Hazmedsafety.com 19 Hazmedsafety.com 20 Hazmedsafety.com 21 7
8 Hazmedsafety.com gaptool.com gaptool.com 24 8
9 800gaptool.com gaptool.com 26 Gap Analysis at Children s Mercy Analyzed USP <800> by section to identify actionable items Created spreadsheet for each item with notes on Necessary changes Responsible individuals Policies that need updated Status Update frequently based on new information and item completion 27 9
10 Gap Analysis at Children s Mercy 28 What a Gap Analysis Cannot Do Show all complexities of the problem that may exist Implementation work Education to staff Minimize barriers to compliance 29 Completing an Assessment of Risk 30 10
11 NIOSH List National Institute for Occupational Safety and Health Updated every two years Three classifications oantineoplastic onon antineoplastic oreproductive only drugs list_ pdf 31 Everything must follow all USP 800 rules Complete an assessment of risk 32 Consider Colchicine Fluconazole Paroxetine all options/ 33 11
12 What Qualifies? NIOSH TABLE 1: ANTINEOPLASTIC Requires manipulation Ex: crushing methotrexate tablets Must follow all USP 800 precautions Final dosage form with no manipulation Ex: counting methotrexate tablets Perform assessment of risk for these agents NIOSH TABLE 2 AND 3: NON ANTINEOPLASTIC AND REPRODUCTIVE ONLY Can perform an assessment of risk for all items Unless using active pharmaceutical ingredients (API) pills/image_b52bc2d de 96db 001cc4c002e0.html 34 Use NIOSH list to create a facility list of hazardous drugs Incorporate into hazardous drug policy and get approval through organization s policy process Review at least annually Separate into two categories API or antineoplastics requiring manipulation Everything else Determine strategies to minimize exposure to employees Evaluate current policies to ensure congruence Create a form to evaluate each dosage form in the everything else list and perform assessment Performing an Assessment of Risk Improving Safe Handling Practices for Hazardous Drugs. Joint Commission Resources Consider These Actions Receipt from wholesaler Transport to storage Storage Transport to and from Compounding areas (sterile and nonsterile) Dispensing area Prepacking area Administration area Offsite area Deactivating, decontaminating, and disinfecting compounding and administration areas Including spills Administration Disposal Education of staff Improving Safe Handling Practices for Hazardous Drugs. Joint Commission Resources
13 Children s Mercy Assessment of Risk NIOSH list evaluated by pharmacists Two classification of drugs Cytotoxic Hazardous Upgrades Asparaginase Isotretinoin Historical items Alemtuzumab Rituximab Pentamidine Update list in Handling Cytotoxic and Hazardous Agents policy Nursing Practice Council P&T Committee Hospital executives 37 Children s Mercy Assessment of Risk Collaboration with Children s Hospital Association members Creation of Access database Meet with Nursing and Environmental Services to discuss proposed handling rules
14 Tips Prioritize your concerns and implement those first Respectfully remind other departments that USP 800 is not a pharmacy issue Be reasonable when deciding how to handle items on Table 2 and Table 3 40 Non Sterile HD Compounding 41 Non Sterile HD Compounding Definition of Compounding: United States Pharmacopeia Chapter 800 Hazardous Drugs Handling in Healthcare Settings
15 Repackaging USP 800 eliminates the ability to repackage tablets in packaging machines Risk of crushing and exposure Cytotoxic vs. hazardous Assessment of risk Buy unit dose Blister packaging 43 It s not just cleaning anymore Deactivate Renders the compound inert or inactive Decontaminate Inactivating, neutralizing, or physically removing hazardous residue Cleaning Process to remove contaminants from objects and surfaces using water, detergents, surfactants, solvents Disinfect Inhibiting or destroying microorganisms 44 Closing Thoughts USP 800 is a minimum requirement It is a supplement to USP 795 and 797 and does not replace it Sensitivity of messaging 45 15
16 Questions 46 16
Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS
Implementing USP 800 ASHLEY DUTY, PHARMD, MS JOANNA ROBINSON, PHARMD, MS Disclosure Ashley Duty has no conflicts of interest to disclose Joanna Robinson has no conflicts of interest to disclose Objectives
More informationImplementing USP
Implementing USP 800 Joanna Robinson, PharmD, MS Inpatient Operations Manager Disclosure I have no conflicts of interest to disclose Objectives 1. Understand the purpose of USP 80 2. Describe how to engage
More information4/18/2018. Improving USP <800> Compliance in a Community Healthcare Organization. Disclosures. Learning Objectives
Improving USP Compliance in a Community Healthcare Organization Brady Conner, Pharm.D. PGY1 Pharmacy Resident St. Vincent Healthcare, Billings, MT 4/20/1018 Disclosures IRB Status: Exempt Co-investigators
More informationIntroduction to USP General Chapter <800> How Will It Affect Federal Pharmacy?
CPE Information and Disclosures Introduction to USP General Chapter How Will It Affect Federal Pharmacy? MAJ Jonathan Bartlett Moncrief Army Health Clinic CPT(P) Seth Mayer Walter Reed National Military
More informationEnsuring Healthcare Worker Safety When Handling Hazardous Drugs: The Joint Position Statement From the Oncology Nursing Society, the American
Ensuring Healthcare Worker Safety When Handling Hazardous Drugs: The Joint Position Statement From the Oncology Nursing Society, the American Society of Clinical Oncology, and the Hematology/Oncology Pharmacy
More informationAdvanced Sterile Product Preparation Training and Certificate Program
Advanced Sterile Product Preparation Training and Certificate Program ACPE Activity Number(s): 0204-0000-16-725-H04-P & T thru to 0204-0000-16-733-H04-P & T Release Date: November 7, 2016 Expiration Date:
More informationPreventing Occupational Exposure to Hazardous Drugs
Preventing Occupational Exposure to Hazardous Drugs Teresa (Terry) Fisk, CIH, CSP, Non-Clinical Loss Control Director, IRMS, Trinity Health fiskt@trinity-health.org 734-343-0907 April 12, 2017 Introduction
More informationCHEMOTHERAPY/HAZARDOUS DRUGS PRECAUTIONS, PREPARATION, ORDERING
CHEMOTHERAPY/HAZARDOUS DRUGS PRECAUTIONS, PREPARATION, ORDERING Naser Z. Alsharif, PharmD, PhD Professor, School of Pharmacy and Health Profeesions Creighton University, Omaha, NE Selected Slides Courtesy
More informationEnsuring Readiness for USP Chapter <800> on Handling Hazardous Drugs: Assessment, Planning, and Implementation
Ensuring Readiness for USP Chapter on Handling Hazardous Drugs: Assessment, Planning, and Implementation Presented as a Midday Symposium and Live Webinar at the 51 st ASHP Midyear Clinical Meeting
More informationUSP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD
USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL KAREN MILKIEWICZ, PHARMD USP 797: A FOCUS ON ANTIMICROBIAL RISK LEVEL ACTIVITY DESCRIPTION On June 1, 2008, The Revision Bulletin to USP Chapter 797, Pharmaceutical
More informationSterile Compounding of Hazardous Drugs
Sterile Compounding of Hazardous Drugs Session II Pamella Ochoa, Pharm.D. Jose Vega, Pharm.D. 2 Objectives List requirements of secondary engineering controls for hazardous compounding Explain requirements
More informationCompounded Sterile Preparations Pharmacy Content Outline May 2018
Compounded Sterile Preparations Pharmacy Content Outline May 2018 The following domains, tasks, and knowledge statements were identified and validated through a role delineation study. The proportion of
More informationLeveraging Nursing Expertise with USP<800>
Leveraging Nursing Expertise with USP Martha Polovich, PhD, RN, AOCN Assistant Professor Byrdine F. Lewis College Of Nursing And Health Professions Disclosure Martha Polovich served as: A volunteer
More informationADMINISTRATIVE CONTROLS FOR MANAGING HAZARDOUS DRUGS
ADMINISTRATIVE CONTROLS FOR MANAGING HAZARDOUS DRUGS TECHNICAL INFORMATION PAPER NO. 56-073-0417 PURPOSE This paper describes several administrative controls for the safe handling of hazardous drugs (HD):
More informationC DRUG DISTRIBUTION SYSTEMS
C DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Hospital pharmacy departments are expected to operate drug distribution systems which are safe for the patient, efficient and economical,
More informationThe Joint Commission Medication Compounding Certification (MDC) FAQs
The Joint Commission will be implementing the new Medication Compounding Certification (MDC) program for hospitals, critical access hospitals, and home care pharmacy organizations in the state of Michigan
More information1.0 Sterile Compounding Personnel
Print Version - ASHP Self-Assessment Tool for Compounding Sterile Preparations Thank you for participating in the ASHP Self-Assessment Tool for determining compliance with USP Chapter requirements.
More informationRULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER STERILE PRODUCT PREPARATION IN PHARMACY PRACTICE TABLE OF CONTENTS
RULES OF THE TENNESSEE BOARD OF PHARMACY CHAPTER 1140-07 STERILE PRODUCT PREPARATION IN PHARMACY PRACTICE TABLE OF CONTENTS 1140-07-.01 Applicability 1140-07-.05 Labeling 1140-07-.02 Standards 1140-07-.06
More informationUSP <800>: Navigating the New Requirements for Handling Hazardous Drugs in the Community Oncology Setting
USP : Navigating the New Requirements for Handling Hazardous Drugs in the Community Oncology Setting Exploratory Paper Nina K. Chavez, MBA, SPHR, FACMPE August 22, 2017 This paper is being submitted
More informationCHAPTER 17 STERILE PRODUCT COMPOUNDING 17-1
CHAPTER 17 STERILE PRODUCT COMPOUNDING 17-1 Sterile Product Compounding Reference: 1) United States Pharmacopeia chapter 797 (USP) 2) CMS: 482.25(b)(1) - All compounding, packaging, and dispensing
More informationThe Leader in Guidance for the Health Information Management Profession. Patient Safety Monitor Journal
The Leader in Guidance for the Health Information Management Profession Patient Safety Monitor Journal Volume 18 Issue No. 1 January 2017 USP : Protecting healthcare workers from hazardous drugs According
More informationONCOLOGY PRACTICE MANAGEMENT
ONCOLOGY PRACTICE MANAGEMENT Christopher A. Fausel, Pharm.D., MHA, BCOP Clinical Manager, Oncology Pharmacy Chair, Hoosier Cancer Research Network Indiana University Simon Cancer Center Indianapolis, Indiana
More informationAssessment of safe antineoplastic drug handling practices in community pharmacies, veterinary settings and long-term care homes in Ontario.
Assessment of safe antineoplastic drug handling practices in community pharmacies, veterinary settings and long-term care homes in Ontario. Sheila Kalenge 1,2 Chun-Yip Hon 3 Kathy Vu 2,4 Henrietta Van
More information11/4/2016. Sterile Compounding: USP<797> Revisions and the Compounding Quality Act. In the 1930 s and 40 s, 60% of all medications were compounded.
Sterile : USP Revisions and the Quality Act Joe Haynes, RPh, CPh, MBA Lead Sterile Products Pharmacist Johns Hopkins All Children s Hospital Objectives: Disclosure: I have no financial interests to
More information6/23/2011. Compounded Sterile Products Update and Review. Learning Goals for the Pharmacist. Learning Goals for the Pharmacy Technician
Compounded Sterile Products- 2011 Update and Review Jo Ann Gibbs, PharmD Director of Pharmacy Byrd Regional Hospital Leesville, LA Learning Goals for the Pharmacist The pharmacist will be able to: 1. Identify
More informationSCOPE PURPOSE. BACKGROUND and DEFINITIONS
POLICIES/PROCEDURES TITLE: Safe Handling of Hazardous Medications SCOPE All pharmacy and nursing staff must have proper knowledge and training in handling techniques for hazardous medications as described
More informationOperational Impacts of Adhering to NIOSH and USP 800 Standards
Operational Impacts of Adhering to NIOSH and USP 800 Standards Jennifer Reddy PharmD, BCPS, BCOP Clinical Oncology Coordinator Sutter Health Corbin Bennett PharmD, MPH Director of Outpatient Infusion Pharmacy
More informationUnderstanding USP 797
Baxa Corporation Understanding USP 797 Technical Paper An Overview of USP General Chapter Pharmaceutical Compounding Sterile Preparations Mike Hurst, RPh, MBA 2004 Baxa Corporation Introduction USP
More informationHazardous Drugs. Controlling the risk in healthcare facilities. By Joseph W. Klancher, Mary Vorndran and William Weiss
Occupational Hazards Occupational Hazards Hazardous Drugs Controlling the risk in healthcare facilities By Joseph W. Klancher, Mary Vorndran and William Weiss Joseph W. Klancher, M.P.H., CSP, is a safety
More informationTo provide information about the role of the pharmacy in Infection Prevention and Control.
TITLE/DESCRIPTION: Pharmacy DEPARTMENT: Pharmacy PERSONNEL: Pharmacy Personnel EFFECTIVE DATE: 1/97 REVISED: 4/97, 7/08, 12/11, 1/15 I. PURPOSE To provide information about the role of the pharmacy in
More informationPharmacy Sterile Compounding Areas
Approved by: Pharmacy Sterile Compounding Areas Corporate Director, Environmental Supports Environmental Services/ Nutrition Food Services Operating Standards Manual Number: Date Approved June 17, 2016
More informationSafe Handling of Hazardous Drugs to Protect Healthcare Workers
41 Safe Handling of Hazardous Drugs to Protect Situation Healthcare personnel who transport, prepare, administer, and dispose of hazardous drugs can be exposed to these toxic agents in the air or on work
More informationPHARMACY SERVICES / MEDICATION USE
25.01.02 Supervision of Pharmacy Activities. In order to provide patient safety, drugs and biologicals must be controlled and distributed in accordance with applicable standards of practice consistent
More informationGENERAL MEDICATION SECURITY MEDICATION STORAGE HOSPITAL ASSESSMENT CRITERIA CATEGORIES
Print Form Clear Form HOSPITAL ASSESSMENT CRITERIA The following chart outlines the hospital pharmacy criteria that is used by Hospital Practice Advisors (HPAs) when conducting a hospital pharmacy assessment.
More informationHazardous Medication Personal Protective Equipment (PPE) Guide and List
Hazardous Medication Personal Protective Equipment (PPE) Guide and List REDUCING OCCUPATIONAL EXPOSURE TO HAZARDOUS MEDICATION FOR ALL STAFF JUNE 2018 (V1.4) 2018 Alberta Health Services (Pharmacy Services,
More information8/3/2010. Influencing factors Staffing Personal / social Work flow Physical environment Organizational factors
State two methods of improving patient safety in oncology nursing Discuss current recommendations for the safe handling of hazardous drugs Describe interventions that reduce the Martha Polovich, PhD, RN,
More informationDepartment Policy. Code: D: MM Entity: Fairview Pharmacy Services. Department: Fairview Home Infusion. Manual: Policy and Procedure Manual
Department Policy Code: D: MM-5615 Entity: Fairview Pharmacy Services Department: Fairview Home Infusion Manual: Policy and Procedure Manual Category: Home Infusion Subject: Chemotherapy Purpose: Ensure
More informationJeanne Moldenhauer (c) Jeanne Moldenhauer
Jeanne Moldenhauer (c) Jeanne Moldenhauer 2013 1 Presentation Overview Conflicts between regulatory and compendial guidance Understanding the requirements for non sterile and terminally sterilized products
More informationUSP <800> and What Changes Will Mean for Oncology Practices November 2, 2016 State Society Education Series
USP and What Changes Will Mean for Oncology Practices November 2, 2016 State Society Education Series Willis C. Triplett, Pharm.D. Comply797 & Comply800 Learning Objectives 1. Understand USP s purported
More informationD DRUG DISTRIBUTION SYSTEMS
D DRUG DISTRIBUTION SYSTEMS JANET HARDING ORAL MEDICATION SYSTEMS Drug distribution systems in the hospital setting should ideally prevent medication errors from occurring. When errors do occur, the system
More informationSURVEY ON THE PRODUCTION AND PREPARATION OF CYTOSTATIC DRUGS
Please name the period you involve for this survey: Date: (month) (year) to (month) (year) Name your country: 1. Identification of your institution Institution: No. of beds in your hospital (if any): No.
More informationKPIC Aseptic Technique Training Program
KPIC Aseptic Technique Training Program By registering for this program, you understand and agree that you must complete the home study portion in order to attend the live portion of the program. Upon
More informationKPIC Aseptic Technique Training Program Friday, August 24 th Saturday, August 25 th, 2018
KPIC Aseptic Technique Training Program Friday, August 24 th Saturday, August 25 th, 2018 Registration Deadline: Friday, August 10 th, 2018 at 8:00 am Program Description: The KPIC Aseptic Technique Training
More informationMeeting New Requirements for Sterile Compounding Webinar
Meeting New Requirements for Sterile Compounding Webinar June 28, 2016 CHA Webinar Welcome Liz Mekjavich California Hospital Association 1 Continuing Education Requirements Full attendance, completion
More informationRecommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline
Recommendations for the Safe Use and Handling of Oral Anti-Cancer Drugs (OACDs) in Community Pharmacy: A Pan-Canadian Consensus Guideline Table of Contents Summary... 2 Introduction... 2 Scope and Relevance...
More informationCHAPTER 2 GENERAL PRACTICE OF PHARMACY REGULATIONS. These regulations are promulgated as authorized by the Act.
CHAPTER 2 GENERAL PRACTICE OF PHARMACY REGULATIONS Section 1. Authority. These regulations are promulgated as authorized by the Act. Section 2. Purpose. The purpose of this regulation is to coordinate
More informationCompounding Conundrums: Outsourcing Shortages, Clean Room Design, and Hazardous Drugs 2012 Midyear Clinical Meeting
Disclosures Patricia Kienle reports the following relevant financial relationships Employee of Cardinal Health Compounding Conundrums Outsourcing, Shortages, Clean Room Design, and Hazardous Drugs Luci
More informationSURVEY ON THE PRODUCTION AND PREPARATION OF CYTOSTATIC DRUGS
Please fax the complete questionnaire to: +49 (40) 79 14 36 01 SURVEY ON THE PRODUCTION AND PREPARATION OF CYTOSTATIC DRUGS Date: 1. Identification of your institution Institution: No. of departments:
More informationLUNCH AND LEARN. Proposed USP 800 Safely Handling Hazardous Drugs August 8, 2014
LUNCH AND LEARN Proposed USP 800 Safely Handling Hazardous Drugs August 8, 2014 Featured Speaker: Firouzan 'Fred' Massoomi, Pharm.D., FASHP Pharmacy Operations Coordinator, Department of Pharmacy Services
More informationHAZARDOUS DRUGS: HANDLING PRECAUTIONS BACKGROUND PURPOSE POLICY STATEMENTS
BACKGROUND Hazardous drugs are drugs that pose a potential health risk to workers who may be exposed to them during receipt, transport, preparation, administration, or disposal. These drugs require special
More informationSTATE OF FLORIDA DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH, STATE OF FLORIDA DEPARTMENT OF HEALTH PETITIONER, v. CASE NO. 2017-05245 SOUTHEAST COMPOUNDING PHARMACY, LLC, RESPON DENT. ADMINISTRATIVE COMPLAINT COMES NOW, Petitioner, Department
More informationIntroduction to Pharmacy Practice
Introduction to Pharmacy Practice Learning Outcomes Compare & contrast technician & pharmacist roles Understand licensing, certification, registration terms Describe advantages of formal training for technicians
More informationPROMOTING BEST PRACTICES FOR THE SAFE HANDLING OF HAZARDOUS DRUGS A CONTINUING EDUCATION WEBINAR
PROMOTING BEST PRACTICES FOR THE SAFE HANDLING OF HAZARDOUS DRUGS A CONTINUING EDUCATION WEBINAR PROMOTING BEST PRACTICES FOR THE SAFE HANDLING OF HAZARDOUS DRUGS Firouzan Fred Massoomi, PharmD, FASHP
More informationENDORSED BY THE GOVERNANCE COMMITTEE
Guideline for Expectant Mothers and those trying to conceive involved in the administration of and/or the care of patients receiving chemotherapy/monoclonal antibodies Version History Version Date Brief
More informationToolkit for Safe Handling of Hazardous Drugs for Nurses in Oncology
Toolkit for Safe Handling of Hazardous Drugs for Nurses in Oncology Contents Safe handling begins with education Where do we look for standards and guidelines? What is USP and how will it impact
More informationImplementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System
Implementation of Remote Management of Compounded Sterile Products through the use of a Telepharmacy System Jerry Siegel Pharm.D., FASHP Howard Cohen M.S.,RPh FASHP Marianne Ivey Pharm.D., FASHP Safe Medication
More informationCASPER COLLEGE COURSE SYLLABUS. Pharmacy Simulation Laboratory II PHTK 1610 H1. Office Phone: Office: LH 104
CASPER COLLEGE COURSE SYLLABUS Pharmacy Simulation Laboratory II PHTK 1610 H1 Semester/Year: Spring 2018 Lecture Hours: 2 Lab Hours: 4 Credit Hours: 4 Class Time: 2-6 p.m. Days: Wednesday Room: LH 103
More informationImproving Sterile Compounding: Impact of New Regulations, Standards and Guidelines PharMEDium Lunch and Learn Series LUNCH AND LEARN
LUNCH AND LEARN Improving Sterile Compounding: Impact of New Regulations, Standards and Guidelines September 9, 2016 Featured Speaker: Darryl S. Rich, PharmD, MBA, FASHP Medication Safety Specialist Institute
More informationExternal Assessment Specifications Document
External Assessment Specifications Document Curriculum Code: 321301000 Qualification Title: Occupational Certificate: Pharmacy Technician NQF Level: 6 321301000 - Pharmacy Technician External Assessment
More informationUSP <797> PERSONAL HYGEINE PERSONAL PROTECTION EQUIPMENT
USP PERSONAL HYGEINE PERSONAL PROTECTION EQUIPMENT PERSONAL HYGEINE PERSONAL PROTECTIVE EQUIPMENT Compounding personnel must maintain proper personal hygiene and use personal protective equipment
More informationArizona Department of Health Services Licensing and CMS Deficient Practices
Arizona Department of Health Services Licensing and CMS Deficient Practices Connie Belden, RN., Bureau of Medical Facility Licensing August 8, 2013 General Comments Deficient Practices per visit Trend
More informationRisk Assessment for the TB Laboratory
Risk Assessment for the TB Laboratory Wisconsin Mycobacteriology Laboratory Network (WMLN) Annual Confererence November 4, 2015 Erin Bowles Erin.bowles@slh.wisc.edu 608-890-1616 1 A National Biosafety
More informationEHR] A INSPECTION REPORT. Guy s Hospital Pharmacy St Thomas Street London SE1 9RT. Safeguarding public health
Safeguarding public health EHR] A INSPECTION REPORT Guy s Hospital Pharmacy St Thomas Street London SE1 9RT Head Office: Inspection & Standards Division, Market Towers, I Nine Elms Lane, Vauxhall, London,
More informationSTATE OF FLORIDA DEPARTMENT OF HEALTH
DEPARTMENT OF HEALTH, STATE OF FLORIDA DEPARTMENT OF HEALTH PETITIONER, v. CASE NO. 2017-10306 VITAL RX, INC., RESPONDENT. ADMINISTRATIVE COMPLAINT COMES NOW, Petitioner, Department of Health, by and through
More informationASHP Guidelines on Compounding Sterile Preparations
Drug Distribution and Control: Preparation and Handling Guidelines 111 ASHP Guidelines on Compounding Sterile Preparations Purpose The compounding of medications is a fundamental part of pharmacy practice.
More informationDefinitions: In this chapter, unless the context or subject matter otherwise requires:
CHAPTER 61-02-01 Final Copy PHARMACY PERMITS Section 61-02-01-01 Permit Required 61-02-01-02 Application for Permit 61-02-01-03 Pharmaceutical Compounding Standards 61-02-01-04 Permit Not Transferable
More informationUSP <797>: Making the Case for Increasing Environmental Controls in Pharmaceutical Compounding. By Eric S. Kastango, M.B.A., R.Ph.
USP : Making the Case for Increasing Environmental Controls in Pharmaceutical Compounding By Eric S. Kastango, M.B.A., R.Ph., FASHP SUPPORTED BY AN UNRESTRICTED EDUCATIONAL GRANT FROM HOSPIRA, INC.
More informationHospital and Other Healthcare Facilities
Hospital and Other Healthcare Facilities Council Progress Report December 2015 Judy Chong, RPh, BScPhm Manager, Hospital and Other Healthcare Facilities Agenda Background Drug Preparation Premises (DPPs)
More informationVeterinary. Hazardous Drug Program Guide
This guide, developed by DOSH staff, has been reviewed by hazardous drug stakeholders, and is advisory in nature, informational in content, and intended to assist employers in providing a safe and healthful
More informationAccess to the laboratory is restricted when work is being conducted; and
APPENDIX E-2: Biosafety Level 2 (BSL-2) The following is taken from the Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5 th Edition, February 2009 Centers for Disease Control and Prevention
More informationUSP <797> does not apply to the administration of medications.
December 5, 2017 Michael Bullek, BSP, RPh Administrator/Chief of Compliance State of New Hampshire Office of Professional Licensure and Certification Division of Health Professions Board of Pharmacy 121
More informationClinical IQ, LLC September 2, 2009
The Top 10 Gaps in USP 797 Compliance Eric S. Kastango, MBA, RPH, FASHP Clinical IQ, LLC September 2, 2009 eric.kastango@clinicaliq.com Disclaimer Although I am a member of the USP Sterile Compounding
More informationNewfoundland and Labrador Pharmacy Board Standards of Practice
Newfoundland and Labrador Pharmacy Board Standards of Practice Standards for Pharmacy Compounding of Hazardous Sterile Preparations Adopted February 2017 MODEL STANDARDS FOR PHARMACY COMPOUNDING OF HAZARDOUS
More informationPharmacy General Personnel
Pharmacy The Pharmacy Department is an important area for infection control because its products are potentially dispensed to all patients. Contamination of medications or other pharmaceuticals whether
More informationFlorida Department of Education Curriculum Framework PSAV
Florida Department of Education Curriculum Framework 2018 2019 Program Title: Program Type: Career Cluster: Pharmacy Technician Career Preparatory Health Science Program Number H170500 CIP Number 0351080506
More informationNON-STERILE PREPARATIONS
MODEL STANDARDS FOR PHARMACY COMPOUNDING OF NON-STERILE PREPARATIONS PUBLISHED WITH THE GUIDANCE DOCUMENT FOR PHARMACY COMPOUNDING OF NON-STERILE PREPARATION Model Standards for Pharmacy Compounding of
More informationUrinalysis and Body Fluids
Urinalysis and Body Fluids Unit 1 A Safety in the Clinical Laboratory Types of Safety Hazards Physical risks Sharps hazard Electrical hazard Radioactive hazard Chemical exposure risk Fire / explosive hazards
More informationInfection Prevention Checklist Section I: Policies and Practices I.1 Administrative Measures
Infection Prevention Checklist Section I: Policies and Practices I.1 Administrative Measures Facility name:... Completed by:... Date:... A. Written infection prevention policies and procedures specific
More informationPractice Spotlight. Children's Hospital Central California Madera, California
Practice Spotlight Children's Hospital Central California Madera, California http://www.childrenscentralcal.org Richard I. Sakai, Pharm.D., FASHP, FCSHP Director of Pharmacy Services IN YOUR VIEW, HOW
More informationStrands & Standards PHARMACY TECHNICIAN
Strands & Standards PHARMACY TECHNICIAN COURSE DESCRIPTION An instructional program that prepares individuals to support pharmacists. This includes pharmacist approved consultation regarding Over-the-Counter
More informationSAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY
SAFE HANDLING OF HAZARDOUS MEDICATIONS (CYTOTOXIC AND NON-CYTOTOXIC) POLICY POLICY # 110.160.010 NEWLY REVISED: OCTOBER 2015 AVAILABLE AT: HTTP://HOME.WRHA.MB.CA/PROG/MEDQUALITY/POLICIES.PHP Safe Handling
More informationSTANDARD PRECAUTIONS POLICY Page 1 of 8 Reviewed: May 2017
Page 1 of 8 Policy Applies to: All Mercy Staff, Credentialed Specialists, Allied Health Professionals, students, patients, visitors and contractors will be supported to meet policy requirements Related
More informationwe ve got you COVERED.
we ve got you COVERED. gowns for every exposure level full protection without compromising comfort or limiting movement TIDI Products understands that not all situations call for the same isolation gown.
More informationNORTH DAKOTA STATE BOARD OF PHARMACY PRACTICE ACT PAGE #
KEY= 43 15 NORTH DAKOTA CENTURY CODE {LAW} 19 STATUTE {LAW} 61 ADMINISTRATIVE CODE {RULE/REGULATION} NORTH DAKOTA STATE BOARD OF PHARMACY PRACTICE ACT PAGE # Administration Definition 43-15-01... 94 Adulteration
More informationMODULE 5: HCWM Planning in a Healthcare Facility
MODULE 5: HCWM Planning in a Healthcare Facility Module Overview Describe the principles and framework for management of healthcare waste Describe the steps for developing a waste management plan Identify
More informationSARASOTA MEMORIAL HOSPITAL
SARASOTA MEMORIAL HOSPITAL TITLE: NURSING PROCEDURE HANDLING LIQUID CHEMOTHERAPY SPILLS DATE: REVIEWED: PAGES: 03/86 11/17 1 of 6 PS1094 ISSUED FOR: Nursing RESPONSIBILITY: RN PURPOSE: OBJECTIVE: KNOWLEDGE
More informationProfessional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess.
Professional Student Outcomes (PSOs) - the academic knowledge, skills, and attitudes that a pharmacy graduate should possess. Number Outcome SBA SBA-1 SBA-1.1 SBA-1.2 SBA-1.3 SBA-1.4 SBA-1.5 SBA-1.6 SBA-1.7
More informationAbout OMICS Group Conferences
About OMICS Group OMICS Group International is an amalgamation of Open Access publications and worldwide international science conferences and events. Established in the year 2007 with the sole aim of
More informationHAAD Standard for CBRNE Contaminated Material Management and Disposal Document Ref. Number: HAAD/CBRNECMMD/0.9 Version: 0.9
Document Title: HAAD Standard for CBRNE Contaminated Material Management and Disposal Document Ref. Number: HAAD/CBRNECMMD/0.9 Version: 0.9 Approval Date: 26/03/2017 Document Owner: Applies to: Classification:
More informationSubmitted electronically via: May 20, 2015
Submitted electronically via: http://www.regulations.gov May 20, 2015 Jane Axelrad, JD Associate Director for Policy, CDER Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers
More informationREVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY
REVISED FIP BASEL STATEMENTS ON THE FUTURE OF HOSPITAL PHARMACY Approved September 2014, Bangkok, Thailand, as revisions of the initial 2008 version. Overarching and Governance Statements 1. The overarching
More informationMacomb Community Unit School District No :190 Page 1 of 7 OPERATIONAL SERVICES
Page 1 of 7 Introduction Since one cannot tell who may be carrying HIV, hepatitis B, or any bloodborne pathogen, all workers who may contact human blood or body fluids are at risk. For this reason, the
More informationInstitutional Pharmacy Practice (PHRA 1349) Credit: 3 semester credit hours (2 hours lecture, 2 hours lab)
Institutional Pharmacy Practice (PHRA 1349) Credit: 3 semester credit hours (2 hours lecture, 2 hours lab) Prerequisite: Complete the TSI Assessment Tests Course Description Exploration of the unique role
More informationRE: MHA and MSHP and Joint Comments Proposed 247 CMR Sterile Compounding Regulations
November 10, 2017 David Sencabaugh, R.Ph. Executive Director Board of Registration in Pharmacy 239 Causeway Street, 5th Floor, Ste. 500 Boston, MA 02114 RE: MHA and MSHP and Joint Comments Proposed 247
More informationSystemic anti-cancer therapy Care Pathway
Network Guidance Document Status: Expiry Date: Version Number: Publication Date: Final July 2013 V2 July 2011 Page 1 of 9 Contents Contents... 2 STANDARDS FOR PREPARATION AND PHARMACY... 3 1.1 Facilities
More informationA shortage of everything except ERRORS
Disclosure Succinylcholine Propofol Vitamin K Lorazepam Diltiazem Drug Shortages Current Status & State Survey Results Bill Stevenson Director of Pharmacy Oconee Medical Center I do not have a vested interest
More informationObjectives. Institutional Pharmacy Practice. Medicare, Medicaid, What s the difference? Medicare, Medicaid, What s the difference?
Objectives Institutional Pharmacy Practice Donald H. Williams, RPh, FASHP Affiliate Professor University of Washington To discuss the regulation of institutional pharmacy practice in Washington To differentiate
More informationSurface Contamination
Processes to Address Surface Contamination A Midday Symposium and Live Webinar conducted at the 52nd ASHP Midyear Clinical Meeting and Exhibition Monday, December 4, 2017 11:30 a.m. 1:00 p.m. Orlando,
More informationDoD Space Planning Criteria for Health Facilities Pharmacy (Chapter 5.5)5.5.1 PURPOSE AND SCOPE
(Chapter ).1 PURPOSE AND SCOPE This document provides space planning criteria for pharmacy activities in DoD medical facilities. These criteria will be used to plan low volume, medium volume, and high
More information9/29/2014. Disclosure: I, Amber Sanders have no financial relationship to disclose. Objectives. Medication Safety in Pediatric Populations
Medication Safety in Pediatric Populations By: Amber Sanders Disclosure: I, Amber Sanders have no financial relationship to disclose Objectives Identify Pediatric Medication Safety Guidelines Institute
More information